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In English
Communications Regulatory Au-
thority oversees the legality of
product placement in Finland.
Drug marketing posing as
neutral communication has be-
come more common, but this can
be combated jointly by all of the
players in the health sector, in-
cluding the public. Communica-
tions to the public regarding dis-
eases or health issues, without
their having requested it, must
not exclusively market a specific
prescription drug, even indirectly.
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The National Agency for Medi-
cines’ Medical Devices depart-
ment regulates the manufacture
and marketing of medical de-
vices, and promotes the safety
of their use. The responsibilities
of the Medical Devices section
have been the responsibility of
NAM since 1995. 
In 2008, the Ministry of So-
cial Affairs and Health intro-
duced a plan to reform the ad-
ministration of pharmaceutical
services. In the summer of
2009, a new Act was passed re-
garding the Finnish Medicines
Agency, Fimea. Fimea is respon-
sible for promoting the health
and safety of the population by
regulating drugs and blood and
tissue products, and by develop-
ing the pharmaceutical sector.
According to the Act, the re-
sponsibilities of the Medical De-
vices section will be transferred
to the National Supervisory Au-
thority for Welfare and Health
as of 1.11.2009. 
The National Supervisory
Authority for Welfare and
Health (Valvira) is a new cen-
tral body that was formed on
1.1.2009 by a merger between
the National Product Control
Agency for Welfare and Health
(STTV) and the National Au-
thority for Medicolegal Affairs
(TEO). By offering guidance
and supervision, Valvira works
to improve the management of
health risks in the environment,
the standard of legal protection,
and the quality of social welfare
and health services. 
From 1.11.2009, the new
contact details for all issues re-
lating to medical devices will be
as follows:
Valvira 
(National Supervisory Authority
for Welfare and Health)
Lintulahdenkuja 4
PL 210 
FI-00531 Helsinki 
Tel: +358-(0)9-772 920
(exchange)
Fax: +358-(0)9-772 2138
E-mail:
firstname.surname@ valvira.fi
kirjaamo@valvira.fi
www.valvira.fi
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